Asbestos is known to induce malignant mesothelioma (MM) and other asbestos-related diseases. It is directly genotoxic by inducing DNA strand breaks and cytotoxic by promoting apoptosis in lung target cells. Poly(ADPribose) polymerase-1 (PARP1) is a nuclear zinc-finger protein with a function as a DNA damage sensor. To determine whether PARP1 is involved in asbestosinduced carcinogenesis, PARP1 expression and activity as well as DNA damage and repair were evaluated in circulating cells of asbestos-exposed subjects, MM patients and age-matched controls. PARP1 expression and activity were also evaluated in pleural biopsies of MM patients and compared with normal tissue. Accumulation of the pre-mutagenic 8-hydroxy-2#-deoxyguanosine and elevated PARP1 expression were found both in asbestos-exposed subjects and MM patients. Although PARP1 was highly expressed, its activity was relatively low. Low DNA repair efficiency was observed in lymphocytes from MM patients. High expression of PARP1 associated with low PARP activity was also found in MM biopsies. To mimic PARP1 dysfunction, PARP1 expression and activity were induced in immortalised mesothelial cells by their exposure to asbestos in the presence of a PARP1 inhibitor, which resulted in transformation of the cells. We propose that exposure to asbestos inhibits the PARP1 activity possibly resulting in higher DNA instability, thus causing malignant transformation.
Introduction
The aetiology of asbestos-induced malignant mesothelioma (MM) and other asbestos-related diseases is not clear. Genotoxicity of asbestos implies the generation of iron-derived reactive oxygen species (ROS) and reactive nitrogen species, which represent the key events in neoplastic transformation. Asbestos fibres may produce a variety of lesions in cellular DNA, such as single-or double-strand breaks (SSBs or DSBs) and base damage (1). 8-Hydroxy-2#-deoxyguanosine (8OHdG), a major product of such oxidative damage (2), causes G:C and T:A transversions (3). These substitutions have been reported as the sites of spontaneous mutations and may be largely responsible for the onset of carcinogenesis and cell proliferation, ultimately leading to cancer manifestation (4) . Repair of these lesions in many cases will restore the physiological DNA structure. In some instances, abnormal repair may occur, resulting in mutations, chromosomal aberrations, and, ultimately, in malignant transformation.
DNA repair plays a key role in limiting the extent of DNA damage and the accumulation of mutated DNA bases. Poly(ADP-Ribose) polymerase-1 (PARP1) is a nuclear zincfinger protein, which functions as a DNA damage sensor (5) . In response to DNA damage caused by environmental genotoxic agents and endogenous cellular reactions, PARP binds rapidly to DNA strand breaks and catalyses the transfer of ADP-ribose residues from its substrate, NAD þ , to a number of nuclear chromatin-associated proteins, including p53, NFjB, histones, AP-1, AP-2, topoisomerase I and II, and PARP itself (6, 7) . Automodified PARP1 attracts the base excision repair (BER) complex, facilitating the restoration of DNA (8) . A lack of PARP activity causes hypersensitivity to genotoxic agents and elevated chromosomal abnormality. PARP1 overactivation by massive DNA breakage leads to depletion of its substrate, NAD þ , as well as ATP (9) . These events are responsible for alteration of the mitochondrial potential and may be involved in the release of the apoptosis-inducing factor (10) . PARP1-dependent cell death is involved in the prevention of carcinogenesis (11) . A relationship of genetic alterations in PARP1 with carcinogenesis has been reported by several authors. The heterozygous Met129Thr mutation in the PARP1 protein has been found in germ cell tumours (12) . The Val762Ala single nucleotide polymorphism was found in prostate cancer (13) . The Ala/Ala genotype increases by 2-fold the risk of developing oesophageal and lung cancer in Chinese smokers (14) . Although impaired PARP1 activity is related to tumour appearance, a report showed that PARP1 knockout mice are protected against chemically induced skin carcinogenesis (15) . PARP1 abolition appears to impair the promotion of skin carcinogenesis by interfering with the activation of NFjB, a key transcription factor involved in cell proliferation and inflammation.
To determine whether PARP1 is involved in asbestosinduced carcinogenesis, its expression and activity, accumulation of 8OHdG adducts as well as DNA damage and repair were evaluated in circulating cells of asbestos-exposed subjects, MM patients and age-matched controls. PARP1 expression and activity were also evaluated in pleural biopsies of MM patients and compared with normal tissue. Further, PARP1 expression and activity were induced in non-malignant mesothelial cells by their exposure to asbestos fibres in the presence or absence of the PARP1 inhibitor 3-aminobenzamide (3-ABA), and the malignant status of the cells was evaluated.
Materials and methods

Study population
Three groups of subjects were included in the study: asbestos-exposed subjects, patients with MM and age-matched controls (no exposure to asbestos).
Forty-two subjects (mean age 64 AE 8 years, 40 males, 2 females) with a history of asbestos exposure were enrolled in the Institute of Occupational Medicine, Polytechnic University of Marche, Ancona, Italy. The participants were interviewed by trained personnel and answered a detailed questionnaire on the duration of asbestos exposure, smoking and occupational tasks. The subjects had been exposed to asbestos dust on average for 23.3 AE 10.7 years. Smokers (20, 48%), ex-smokers (5, 12%) and non-smokers (17, 40%) were examined. Each subject underwent lung function analysis, chest radiography and high-resolution computer tomography. Evidence of asbestos-related diseases (fibrosis and pleural plaques) was found in 11 (26%) subjects.
Twenty-five patients (mean age 69 AE 10 years; 21 males, 4 females) diagnosed for MM were recruited in the Oncology Clinic of the University Hospital of Ancona, Italy. Smokers (11, 44%), ex-smokers (4, 16%) and nonsmokers (10, 40%) were examined. Exclusion criteria were the presence or suspicion of any infectious disease or previous radical surgery, radiotherapy and chemotherapy for MM. Pathological diagnosis was performed on pleural biopsies obtained by thoracoscopy or thoracotomy. Tumours were classified as epithelial in 13, mixed in 6 and sarcomatoid in 6 patients.
The control group consisted of 30 age-matched subjects (mean age 63 AE 9 years; 19 males, 11 females). Smokers (13, 43%), ex-smokers (5, 16%) and non-smokers (12, 40%) were examined. The subjects were undergoing screening radiography for chemoprevention in the Pneumology Clinic of the University Hospital of Ancona, Italy. None of them had ever been exposed to asbestos as documented by their occupational histories. All subjects had normal chest radiographs.
All subjects filled in a questionnaire including their informed consent and provided a blood sample. The study was carried out according to the Helsinki Declaration and approved by the Ethical Committee of the University Hospital of Marche, Italy.
Blood and biopsy sampling Two samples of venous blood were collected from each subject in EDTA at the time of clinical examination for lymphocyte isolation. Whole blood (7 ml) was immediately centrifuged at 1500 Â g (20°C, 15 min). The buffy coat was removed, placed in a 15-ml Falcon tube and resuspended in 4 ml of PBS. The suspension was then layered onto 4 ml of Lympholyte-H (Cederlane, Hornby, Ontario, Canada) and centrifuged at 1000 Â g (20°C, 30 min). The resulting cloudy layer above the lympholyte was collected, placed in a 15-ml Falcon tube filled with PBS and centrifuged at 230 Â g (20°C, 5 min). Freshly isolated cells were used for the analysis of 8OHdGs as well as SSBs and DNA repair.
Biopsy specimens were obtained from subjects who underwent thoracoscopy or thoracotomy for suspected malignancy. According to the diagnosis, MM and normal mesothelium (NM) tissue was collected. MM biopsies (n 5 4) included tissue diagnosed for MM; NM biopsies (n 5 4) included non-malignant tissue.
8OHdG analysis
The level of 8OHdG was determined in lymphocytes using the fluorometric OxyDNA assay kit (Calbiochem, Darmstadt, Germany) according to the manufacturer's instructions. Briefly, lymphocytes were suspended in 500 ll PBS/500 ll of 2% paraformaldehyde and incubated on ice for 15 min. After two washes in PBS and centrifugation, the cells were resuspended in 50 ll of the blocking solution for 1 h at 37°C. The blocking solution was then removed, 100 ll of the fluorescent probe for 8OHdG added and the samples incubated for 1 h. After washing, the cells were resuspended in the FACS buffer and analysed by flow cytometry (FACSCalibur, BD Pharmingen, Milan, Italy). The results were expressed as mean fluorescence intensity in arbitrary units (AUs).
DNA SSBs and DNA repair assay DNA SSB formation and DNA repair activity were assessed using the comet assay (single cell gel electrophoresis) (16) . Immediately after isolation, lymphocytes were suspended in PBS and SSBs were introduced by their incubation with 100 lM H 2 O 2 on ice for 5 min. The cells suspended in a 24-well plate with the RPMI-1640 medium containing 10% FBS were incubated at 37°C for 6 h. At regular intervals (0, 0.5, 1, 2, 3 and 6 h), aliquots of the samples were collected for comet assay. Immortalised mesothelial Met-5A cells were seeded in 96-plates at 2 Â 10 4 per well, allowed to attach overnight and exposed to crocidolite asbestos fibres (10 lg/cm 2 ) in the presence or absence of the PARP inhibitor 3-ABA at 2 mM (Sigma, St Louis, MO, USA). At regular intervals, cells were harvested for comet assay.
The comet assay was performed as follow: the cells were suspended in 80 ll of 1% low melting point agarose (Sigma) at 37°C and placed on a glass microscope slide (precoated with agarose to aid attachment of the gels). Two gels were prepared for each sample. The gels were allowed to set at 4°C and lysed overnight in 2.5 M NaCl, 0.1 M Na 2 EDTA, 10 mM Tris-HCl, pH 10, 1% Triton X-100 at 4°C. The slides were immersed in 0.3 M NaOH, 1 mM Na 2 EDTA for 40 min at 4°C before electrophoresis at 0.8 V/cm for 30 min. After neutralisation, the gels were stained with 4#,6-diamidine-2#-phenylindole dihydrochloride (DAPI) and viewed in a fluorescence microscope. The slides were blind scored by the same operator classifying the comets into five categories (0-4) according to the extent of DNA migration. The classification was carried out on the basis of the comet appearance (i.e. tail length, head diameter and intensity) as described elsewhere (17) . The number of comets counted on each slide was 100. Each sample was analysed in duplicate and the value of oxidative damage was expressed in AUs (range 0-400).
The capacity of cells to repair H 2 O 2 -induced strand breaks was determined by evaluating the persistence of DNA damage over time. The DNA repair curves are expressed as a percentage variation with respect to the DNA damage basal value. The rate of DNA repair, first-order rate constant K (min À1 ), maximum velocity of repair V max (AU Â 10
À3
/min) and half-life t 1/2 (h) were determined using plots of data obtained from the initial time (t i ) of induced DNA damage level (C i ) to the final time (t f ) when damage was completely repaired (C f ) according to the following formulas: K 5 (logC i À logC f )/(t f À t i ), V max 5 K Â C i and t 1/2 5 log2/K. The area under curve was also evaluated by the trapezoidal area method and expressed as AU/min.
Assessment of PARP activity PARP1 activity was evaluated using the universal colorimetric PARP assay kit (Trevigen, Gaithersburg, MD, USA) based on the incorporation of biotinylated ADP-ribose onto histone proteins. Cell and tissue lysates containing 50 lg of protein were loaded into 96-well plates coated with histones and biotinylated poly-ADP-ribose, allowed to incubate for 1 h, treated with streptavidinhorseradish peroxidase (HRP) and read at 450 nm in a ELISA plate-reader (Sunrise, Tecan, Milan, Italy). The PARP activity was expressed as unit PARP/ mg of protein.
qRT-PCR The PARP1 gene expression was evaluated by quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) using specific primers as follows: PARP1 forward, 5#-AAGCCCTAAAGGCTC AGAAC-3#, PARP1 reverse, 5#-AGAAGGCACTTGCTGCTTGT-3#. The GAPDH gene was chosen as a housekeeping gene and the primers used were: forward, 5#-TCC ACTGGCGTCTTCACC-3#, reverse, 5#-GGCAGAGATGATGACCCTTTT-3#. Total RNA from cells and tissue samples was isolated using the SV total RNA isolation system (Promega Italia, Milan, Italy) according to the manufacturer's instructions. Total RNA (2 lg) was reverse transcribed using the RNA PCR MMLV kit (Promega Italia), and the resulting cDNA was used as a PCR template. The mRNA levels were determined by qRT-PCR (IQ5 real-time PCR detection System, BioRad, Milan, Italy) according to the manufacturer's instructions. PCR reaction mixture contained SYBR green (BioRad), cDNA and primers. The fold change in relative PARP1 expression was calculated using the equation 2 ÀD(DCt) .
Western blotting
The cells and tissue samples were lysed in a buffer containing 150 mM NaCl, 50 mM Tris-HCl (pH 7.2), 1 mM EDTA (pH 8), 1% Nonidet P-40, 0.1% SDS, 0.5% sodium deoxycholate and a cocktail of protease inhibitors (2 lg/ ml aprotinin, 2 lg/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride and 2 lg/ml pepstatin) and stored at À80°C until analysis. The protein level was quantified using the Bradford assay (Sigma). Fifty micrograms of the lysate was separated on a 12.5 SDS-PAGE gel and transferred to nitrocellulose membranes (Protran, Whatman, Dassel, Germany). After blocking for 1 h with 5% non-fat milk in PBS-T (PBS-Tween), the membranes were incubated with monoclonal anti-PARP1 IgG (C2-10, Trevigen), monoclonal anticaspase-3 IgG (Cell Signaling Technology, Beverly, MA, USA) and polyclonal anti-b-actin IgG (Bethyl, Montgomery, TX) at 4°C overnight.
After washing with PBS-T, the membranes were incubated with an HRPconjugated secondary antibody for 2 h at room temperature. Specific bands were detected using the ECL detection system (Pierce Biotechnology, Rockford, IL, USA). Band intensities were evaluated by ChemiDoc (BioRad) using Quantity One software (BioRad).
TUNEL assay MM (n 5 3) and NM (n 5 3) tissue samples were fixed in formalin and embedded in paraffin. Sections were subjected to the TUNEL assay (In Situ Cell Death Detection Kit, Roche, Mannheim, Germany) according to the manufacturer's instructions. TUNEL positivity (green fluorescent) was considered as a marker of apoptosis. The haematoxylin-eosin staining was used for histology evaluation. Immortalised mesothelial Met-5A cells were placed in 6-well plates at 3 Â 10 5 per well on glass coverslips. The cells were allowed to attach overnight and then over time exposed to crocidolite asbestos fibres (10 lg/cm 2 ) in the presence and absence of the PARP inhibitor 3-ABA (2 mM). After the treatment, cell DNA SSBs were stained by TUNEL assay (TACS-XL-Blue, Trevigen) and viewed in an optical microscope (Zeiss, Axiocam MRc5, magnification Â60).
Cell culture
Immortalised mesothelial cells, Met-5A (American Type Culture Collection, Rockville, MD), were grown in the RPMI-1640 medium supplemented with 2 mM L-glutamine, 100 U/ml penicillin, 100 lg/ml streptomycin and 10% FBS. The cells were cultured at 37°C and 5% CO 2 in a humidified atmosphere.
Soft agar colony-forming assay
The soft-agar assay was performed to evaluate cell transformation. Met-5A cells (10 4 ) were seeded in 24-well plates in RPMI-1640 medium containing crocidolite asbestos fibres (10 lg/cm 2 ) and 0.35% low-melting point (LMP) agar overlying a 0.7% LMP agar layer, in the presence or absence of the PARP1 inhibitor 3-ABA at 2 mM (Sigma).
The cells were cultured at 37°C in 5% CO 2 for 30 days. Every 7 days, 500 ll of fresh medium was added to each well. The formed colonies were visualised in an optical microscope and photographed. The assays were performed in triplicates of three independent experiments. The results were expressed as percentage of plated cells that formed colonies relative to an untreated control.
Statistical analysis
Results were expressed as mean AE SD. The one-way analysis of variance tests followed by Bonferroni post-hoc analysis were performed for multiple comparisons. Comparisons between two groups were performed using the ttest. Logistic and multiple regression analyses were used to estimate the influence of independent variables, such as age, sex, smoking and duration of exposure to asbestos on PARP1 expression and activity and on 8OHdG levels. The correlation analysis was evaluated via the Pearson r coefficient, and values with P , 0.05 were considered statistically significant. All statistical analyses were performed with the SPSS v.15 statistical software (SPSS, Chicago, IL, USA).
Results
PARP1 expression and activity in circulating cells and biopsies PARP1 protein expression was significantly increased in circulating lymphocytes of asbestos-exposed subjects ( Figure  1A and B) . In the lymphocytes of these subjects, a 4-fold increase of the PARP1 gene expression with respect to the controls was also observed (P , 0.001; Figure 1C ). Although PARP1 was highly expressed, its activity was found to be low with respect to that of the controls (P , 0.0001; Figure 1D ). An increase in the PARP1 gene expression was also found in MM patients, where it was 2.6-fold higher than in the controls (P , 0.0001; Figure 1C ). The enhanced gene expression was not reflected by increased levels of the intact PARP1 protein, while majority of the PARP1 protein was found for MM patients to be in the cleaved form ( Figure 1B ). This finding may be reconciled with caspase-3 activation, evaluated via the presence of the p17/p12 forms of the protein, observed in MM subjects ( Figure 1B) .
Considerably overexpressed PARP1 was found in tumour biopsies with levels some 12-fold higher than those in normal tissue (Figure 2A ). Increased PARP1 expression was shown Fig. 1. (A) Distribution of PARP1 protein expression in circulating lymphocytes of asbestos-exposed subjects (Exp), MM patients (MM) and age-matched controls (Ctrl). PARP1 protein was detected by western blot analysis and data expressed as band density normalised to b-actin. (B) Representative western blot of PARP1 and caspase-3 in lymphocyte extracts of control, asbestos-exposed and MM subjects. (C) mRNA PARP1 relative fold change in lymphocytes of asbestos-exposed and MM subjects with respect to the controls. (D) PARP activity in circulating lymphocytes of the individual study groups. The symbol '*' denotes significant differences in data of asbestos-exposed subjects and MM patients versus age-matched controls, with P , 0.05.
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by western blot analysis, and PARP1 cleavage was observed in both malignant and normal samples ( Figure 2B ). The truncated PARP1 found in the MM tissue samples corresponds to the putative apoptosis process as indicated by the presence of active caspase-3 and TUNEL-positive MM biopsies ( Figure 2C ). Although total PARP1 was highly expressed in the malignant tissue, its poly(ADP-ribosyl)ation activity was lower compared to normal tissue ( Figure 2D ).
Relationship between PARP1 expression, and DNA damage and repair Compared to controls, asbestos-exposed subjects and MM patients showed a significant increase in the lymphocyte 8OHdG levels ( Figure 3A) . To evaluate whether the low PARP1 activity observed in asbestos-exposed subjects and MM patients would affect DNA repair, lymphocytes isolated from the individual subjects were exposed to an oxidative stimulus (H 2 O 2 at 100 lM) and the kinetics of DNA strand break rejoining were evaluated ( Figure 3B , Table I ). Lymphocytes of both asbestos-exposed and MM subjects showed a higher basal DNA damage (SSB-b) and were more susceptible to oxidation (nSSBs) compared to the controls (Table I) . Relatively fast removal of strand breaks was observed in H 2 O 2 -treated cells of controls; the rate of strand break repair was 48 AE 34 AU/min and the level of DNA breaks formed (SSBs-ox) was reduced by half within 5 h of the treatment. A slight delay in DNA strand break rejoining was detected in cells from asbestos-exposed subjects (repair rate 5 42 AE 26 AU/min). A significant delay in DNA repair was found in MM patients; the repair rate was 17 AE 5 AU/ min, P , 0.05).
Correlations were performed in the combined groups using the Pearson's test. PARP1 protein levels positively correlated with the PARP1 gene expression (R 5 0.422, P , 0.01) and with 8OHdG cell levels (R 5 0.310, P , 0.05). PARP1 activity was associated neither with PARP1 gene and protein expression nor with 8OHdG levels. On the other hand, PARP1 activity positively correlated with the rate of DNA repair (R 5 0.248, P , 0.05). None of the parameters analysed was influenced by age, sex, smoking or the duration of asbestos exposure.
PARP1 activity inhibition induces DNA SSB accumulation and in vitro cell transformation To mimic the in vivo-impaired PARP1 activity, immortalised mesothelial cells (Met-5A) were exposed to crocidolite asbestos fibres in the presence or absence of the PARP inhibitor 3-ABA, and this was followed by evaluation of DNA SSB formation, PARP1 expression and activity as well as cell transformation. Asbestos exposure induced DNA SSBs in Met-5A cells peaking at 4 h. By monitoring the level of SSBs in cells over time after asbestos exposure, it was found that PARP inhibition blocked the rate of SSB rejoining ( Figure 4A ). The asbestos-induced DNA damage was associated with the enhancement of PARP1 protein expression and subsequent PARP1 activity, peaking at 4-8 h and then returning to the baseline value ( Figure 4B ). The inhibition of PARP1 activity was found to be accompanied by increased colony-forming activity of the cells, indicative of their malignant phenotype ( Figure 4C ).
Discussion
As previously observed (18) , human exposure to asbestos fibres significantly increases the steady-state level of 8OHdG in lymphocyte DNA of asbestos-exposed subjects and patients affected by MM with respect to control subjects (cf. Figure 3) .
The increase in the lymphocyte DNA lesions was associated with overexpression of PARP1. It was found that 8OHdG positively correlated with PARP1 gene and protein expression. PARP1 is known to be induced and activated by oxidants (19) . It participates in DNA repair during moderate sublethal oxidative stress. However, severe stress leads to excessive PARP activation, NAD þ consumption and ATP depletion (20) , and finally to necrotic cell death. Oxidants may also cause apoptotic cell death and, consequently, cleavage of PARP especially in situations where NAD depletion is reversible (21) .
In this study, we show that the ROS-induced PARP1 expression is associated with reduced PARP1 activity, both in asbestos-exposed subjects and MM patients (cf. Figure 1) . Reduced PARP1 activity in human peripheral blood lymphocytes has also been observed in human breast, colon and lung cancer (22) . The low lymphocyte PARP1 activity was reflected in a DNA repair delay found in MM patients compared with the control subjects (cf. Figure 3 , Table I ). PARP1 is a substrate for caspase-3. Therefore, we assume that activated caspase-3, detected in lymphocytes of MM patients, cleaves PARP1, which results in its dysfunction. A similar picture was found in the malignant tissue: the high mRNA and protein PARP1 expression observed in the MM tissue samples was not associated with an increase in endogenous PARP1 activity (cf. Figure 2) . The apoptotic process observed in the MM tissue, as demonstrated by the TUNEL positivity and presence of activated caspase-3, may induce PARP1 fragmentation, thereby inhibiting its activity. On the other hand, no significant signs of apoptosis were found in asbestos-exposed subjects. One can argue that in vivo, asbestos exposure may trigger sufficient level of oxidative DNA damage to induce PARP1 expression but not enough damage to promote cellular energy depletion. In vitro studies have shown that asbestos fibres cause a slight DNA damage in mesothelial cells (Met-5A) and have no effect on the cellular energy nucleotides, such as ATP (23) (24) (25) . The maintenance of the energy nucleotide pool and cell viability may be of importance for initiation/promotion of malignant transformation of mesothelial cells exposed to asbestos fibres. Here, we found that asbestos exposure induced SSB formation in Met-5A cells as well as in PARP-inhibited cells (cf. Figure 4A) . In response to DNA damage, PARP1 is activated and binds rapidly to DNA strand. Once activated, PARP1 induces poly(ADP-ribosyl)ation of target proteins including itself, resulting in its inactivation as showed in Figure 4B . Poly(ADPribose) synthesis is required for the recruitment of BER enzymes to sites of oxidative DNA damage. Consistent with a previous observation (26), we found that asbestos-induced SSBs were repaired in Met-5A cells. Accumulation of SSBs was observed in cells where postincision repair was blocked by a PARP inhibitor, as a likely consequence of reduced recruitment of BER enzymes (cf. Figure 4A ). However, it was found that oxidant-induced SSBs did not accumulate in cells depleted in PARP1 using siRNA, suggesting that PARP1 is not required for efficient completion of BER (26, 27) . Based on these results, a mechanism is proposed. When PARP is inhibited, it is trapped at the SSB intermediate formed during BER, whereby blocking their ligation and causing a potential toxic retention of SSBs in the DNA (26) . Therefore, we can postulate that inhibition of PARP1 determines impaired DNA repair, leading to the accumulation of DNA lesions ('initiated' cells). This initiation process is an early event that leads to cell transformation at a later stage (cf. Figure 4C) . (A) 8-Hydroxy-2#-deoxyguanosine (8OHdG) lymphocyte levels of asbestos-exposed subjects (Exp), MM patients (MM) and age-matched controls (Ctrl). (B) Kinetics of DNA strand break rejoining in lymphocytes of asbestos-exposed subjects (Exp, n 5 37), MM patients (MM, n 5 25) and agematched controls (Ctrl, n 5 34) exposed to hydrogen peroxide (H 2 O 2 ). DNA strand break levels were evaluated at the time points indicated using the comet assay. The kinetics of DNA repair is expressed as the percentage variation with respect to the DNA damage basal value. The symbol '*' denotes significantly different data of asbestos-exposed subjects and MM patients versus agematched controls, with P , 0.05.
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Accumulation of SSBs may explain the high toxicity of PARP inhibitors in cells stimulated by genotoxic insults and oxidative stress (28, 29) . Even though there are contradicting data, with others reporting that cells treated with inhibitors of PARP-1 become resistant to various genotoxic agents, such as UV, c-irradiation and free radicals (30, 31) , the function of PARP-1 in free radical-induced cell toxicity is well established. PARP1 plays multiple roles in cellular responses to genotoxic insults (32) , and our in vitro data foster the idea that PARP1 inhibition in immortalised mesothelial cells exposed to asbestos 2 ) and PARP1 expression and activity evaluated over time. (C) The asbestos-induced PARP1 activation was inhibited by the PARP1 inhibitor (3-ABA, 2mM) and soft-agar forming colonies evaluated. The results are expressed as mean AE SD and as representative TUNEL positivity, western blot of PARP1 and soft-agar colony-forming assay of three independent experiments performed in triplicates. promotes their transformation. This is documented for the PARP1-impaired cells by their anchorage-independent growth, which is a common characteristics of cells with acquired malignant phenotype. In summary, our data contribute to the thus far unresolved discussion on the aetiology of mesothelioma, suggesting that asbestos fibres may promote malignant conversion of normal mesothelial cells, a process that is exacerbated by inhibition of the DNA damage-sensing PARP1, a protein involved in DNA repair. These findings contribute to our understanding the molecular mechanism of malignant transformation resulting in mesothelioma, a neoplastic disease with, currently, no viable therapeutic modality (33) (34) (35) (36) (37) .
